🚀 VC round data is live in beta, check it out!
Telemedycyna Polska Valuation Multiples
Discover revenue and EBITDA valuation multiples for Telemedycyna Polska and similar public comparables like Mobile-Health Network Solutions, Aino Health, Monsenso, Brain+ and more.
Telemedycyna Polska Overview
About Telemedycyna Polska
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
Founded
2005
HQ
Employees
35
Website
Sectors
Financials (FY)
EV
$3M
Telemedycyna Polska Financials
Telemedycyna Polska reported last fiscal year revenue of $1M and negative EBITDA of ($322K).
In the same fiscal year, Telemedycyna Polska generated $1M in gross profit, ($322K) in EBITDA losses, and had net loss of ($408K).
Telemedycyna Polska P&L
In the most recent fiscal year, Telemedycyna Polska reported revenue of $1M and EBITDA of ($322K).
Telemedycyna Polska expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $1M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 92% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($322K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (22%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (27%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($408K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (28%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Telemedycyna Polska Stock Performance
Telemedycyna Polska has current market cap of $3M, and enterprise value of $3M.
Market Cap Evolution
Telemedycyna Polska's stock price is $0.21.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3M | $3M | 0.1% | XXX | XXX | XXX | $-0.03 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTelemedycyna Polska Valuation Multiples
Telemedycyna Polska trades at 1.9x EV/Revenue multiple, and (8.6x) EV/EBITDA.
Telemedycyna Polska Financial Valuation Multiples
As of April 19, 2026, Telemedycyna Polska has market cap of $3M and EV of $3M.
Equity research analysts estimate Telemedycyna Polska's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Telemedycyna Polska has a P/E ratio of (7.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV (current) | $3M | XXX | $3M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (8.6x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (7.0x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.1x | XXX | XXX | XXX |
| P/E | — | XXX | (7.0x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (15.9x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Telemedycyna Polska Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Telemedycyna Polska Margins & Growth Rates
Telemedycyna Polska's revenue in the last fiscal year declined by (3%).
Telemedycyna Polska's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.1M for the same period.
Telemedycyna Polska Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (22%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (43%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 119% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Telemedycyna Polska Public Comps
See public comps and valuation multiples for other Health Data & Analytics and Healthcare Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Telemedycyna Polska | XXX | XXX | XXX | XXX | XXX | XXX |
| Mobile-Health Network Solutions | XXX | XXX | XXX | XXX | XXX | XXX |
| Aino Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Monsenso | XXX | XXX | XXX | XXX | XXX | XXX |
| Brain+ | XXX | XXX | XXX | XXX | XXX | XXX |
| Medondo Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Telemedycyna Polska M&A Activity
Telemedycyna Polska acquired XXX companies to date.
Last acquisition by Telemedycyna Polska was on XXXXXXXX, XXXXX. Telemedycyna Polska acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Telemedycyna Polska
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialTelemedycyna Polska Investment Activity
Telemedycyna Polska invested in XXX companies to date.
Telemedycyna Polska made its latest investment on XXXXXXXX, XXXXX. Telemedycyna Polska invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Telemedycyna Polska
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Telemedycyna Polska
| When was Telemedycyna Polska founded? | Telemedycyna Polska was founded in 2005. |
| Where is Telemedycyna Polska headquartered? | Telemedycyna Polska is headquartered in Poland. |
| How many employees does Telemedycyna Polska have? | As of today, Telemedycyna Polska has over 35 employees. |
| Is Telemedycyna Polska publicly listed? | Yes, Telemedycyna Polska is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Telemedycyna Polska? | Telemedycyna Polska trades under TMP ticker. |
| When did Telemedycyna Polska go public? | Telemedycyna Polska went public in 2010. |
| Who are competitors of Telemedycyna Polska? | Telemedycyna Polska main competitors are Mobile-Health Network Solutions, Aino Health, Monsenso, Brain+. |
| What is the current market cap of Telemedycyna Polska? | Telemedycyna Polska's current market cap is $3M. |
| What is the current revenue of Telemedycyna Polska? | Telemedycyna Polska's last fiscal year revenue is $1M. |
| What is the current EV/Revenue multiple of Telemedycyna Polska? | Current revenue multiple of Telemedycyna Polska is 1.9x. |
| Is Telemedycyna Polska profitable? | No, Telemedycyna Polska is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.